Hematopathology of the bone marrow in pediatric cutaneous mastocytosis. A study of 17 patients
- PMID: 2470248
- DOI: 10.1093/ajcp/91.5.558
Hematopathology of the bone marrow in pediatric cutaneous mastocytosis. A study of 17 patients
Abstract
Sixteen bone marrow aspirates and 15 trephine core biopsies from 17 children with cutaneous mastocytosis, of which 15 exhibited urticaria pigmentosa and 2 exhibited diffuse cutaneous mastocytosis, were evaluated for the presence of bone marrow-associated pathologic conditions. Eight bone marrow aspirates from 8 children and 23 trephine core bone marrow biopsies from 16 children who had had evaluation for hematologic abnormalities not associated with cutaneous mastocytosis served as a control population. Eosinophilia was a prominent finding in bone marrows of 9 of 17 patients who had cutaneous mastocytosis. Increased mast cell numbers in bone marrow aspirates were observed in 5 children with cutaneous mastocytosis (5 of 16) and in 2 of the control children (2 of 8). Examination of the trephine core bone marrow biopsies obtained from patients with cutaneous mastocytosis demonstrated focal perivascular and paratrabecular aggregates consisting of mast cells, eosinophils, and early myeloid cells in 10 of 15 individuals. Similar lesions were observed in trephine core bone marrow biopsies of 3 of 16 control patients. The focal mast cell lesions characteristic of adult systemic mastocytosis were not observed. The authors conclude that cutaneous mastocytosis in the pediatric age group is rarely associated with definitive bone marrow findings suggestive of systemic mast cell disease and that this observation is consistent with previous reports that cutaneous mastocytosis in the majority of pediatric cases resolves by adulthood.
Similar articles
-
Hematologic aspects of mastocytosis: I: Bone marrow pathology in adult and pediatric systemic mast cell disease.J Invest Dermatol. 1991 Mar;96(3):47S-51S. J Invest Dermatol. 1991. PMID: 2002263
-
Bone marrow involvement in cutaneous mastocytosis.Br J Dermatol. 2001 Mar;144(3):561-6. doi: 10.1046/j.1365-2133.2001.04084.x. Br J Dermatol. 2001. PMID: 11260015
-
The bone marrow in urticaria pigmentosa and systemic mastocytosis. Cell composition and mast cell density in relation to urinary excretion of tele-methylimidazoleacetic acid.Arch Dermatol. 1986 Apr;122(4):422-7. Arch Dermatol. 1986. PMID: 3954410
-
Urticaria pigmentosa: a review of 67 pediatric cases.Pediatr Dermatol. 1994 Jun;11(2):102-6. doi: 10.1111/j.1525-1470.1994.tb00560.x. Pediatr Dermatol. 1994. PMID: 8041646 Review.
-
Cutaneous and systemic mastocytosis in adults. A clinical, histopathological and immunological evaluation in relation to histamine metabolism.Acta Derm Venereol Suppl (Stockh). 1985;115:1-43. Acta Derm Venereol Suppl (Stockh). 1985. PMID: 3901645 Review.
Cited by
-
Regulation of normal and neoplastic human mast cell development in mastocytosis.Trans Am Clin Climatol Assoc. 2005;116:185-203; discussion 203-4. Trans Am Clin Climatol Assoc. 2005. PMID: 16555614 Free PMC article.
-
Pediatric-onset mastocytosis: a long term clinical follow-up and correlation with bone marrow histopathology.Pediatr Blood Cancer. 2009 Oct;53(4):629-34. doi: 10.1002/pbc.22125. Pediatr Blood Cancer. 2009. PMID: 19526526 Free PMC article.
-
Paediatric mastocytosis.Arch Dis Child. 2002 May;86(5):315-9. doi: 10.1136/adc.86.5.315. Arch Dis Child. 2002. PMID: 11970917 Free PMC article. No abstract available.
-
Diagnosis and treatment of cutaneous mastocytosis in children: practical recommendations.Am J Clin Dermatol. 2011 Aug 1;12(4):259-70. doi: 10.2165/11588890-000000000-00000. Am J Clin Dermatol. 2011. PMID: 21668033 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources